« Back to Record
Loibl, S., Loirat, D., Tolaney, S. S., Punie, K., Oliveira, M., Rugo, H. H., Bardia, A., Hurvitz, S., Brufsky, A., Kalinsky, K., Cortes, J., O'Shaughnessy, J., Diéras, V., Carey, L. L., Gianni, L., Gharaibeh, M., Preger, L., Phan, S., Chang, L., Shi, L., & Piccart-Gebhart, M. (2023). Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer. European journal of cancer, 178, 23-33. doi:10.1016/j.ejca.2022.10.003
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371247



